Gang Jia

Zhengzhou, 450003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Discovery of indazole-carboxamide based USP8 inhibitor for immune activation and antitumor response in colorectal cancer.

Discovery of indazole-carboxamide based USP8 inhibitor for immune activation and antitumor response in colorectal cancer.

Journal: Translational oncology

Published: February 25, 2026

CD24 as an innate immune checkpoint in solid tumors: biology, biomarker stratification, and therapeutic translation.

CD24 as an innate immune checkpoint in solid tumors: biology, biomarker stratification, and therapeutic translation.

Journal: Frontiers in immunology

Published: January 28, 2026

The dual roles of lysine-specific demethylase 1 (KDM1A/LSD1) in the modulation of tumor immune microenvironment and its inhibitors in colorectal cancer.

The dual roles of lysine-specific demethylase 1 (KDM1A/LSD1) in the modulation of tumor immune microenvironment and its inhibitors in colorectal cancer.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: November 30, 2025

Discovery of o-aminodiphenyl-based USP7 inhibitor for immune activation and antitumor response in colorectal cancer.

Discovery of o-aminodiphenyl-based USP7 inhibitor for immune activation and antitumor response in colorectal cancer.

Journal: International immunopharmacology

Published: August 12, 2025

Analysis and Exploration of the Relationship Between the Status of Serum Tumor Markers and Clinicopathological Features and Curative Effects in Gastric Cancer and Gastroesophageal Junction Tumor.

Analysis and Exploration of the Relationship Between the Status of Serum Tumor Markers and Clinicopathological Features and Curative Effects in Gastric Cancer and Gastroesophageal Junction Tumor.

Journal: OncoTargets and therapy

Published: June 09, 2025

Analysis and exploration of the association between serum tumor marker status and clinical pathological features, as well as efficacy, in colorectal cancer.

Analysis and exploration of the association between serum tumor marker status and clinical pathological features, as well as efficacy, in colorectal cancer.

Journal: Oncology letters

Published: April 02, 2025

Benzimidazole-based structure optimization to discover novel anti-gastric cancer agents targeting ROS/MAPK pathway.

Benzimidazole-based structure optimization to discover novel anti-gastric cancer agents targeting ROS/MAPK pathway.

Journal: Journal of biochemical and molecular toxicology

Published: January 31, 2024

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC.

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC.

Journal: Frontiers in immunology

Published: January 24, 2024

Targeting HER3 to overcome EGFR TKI resistance in NSCLC.

Targeting HER3 to overcome EGFR TKI resistance in NSCLC.

Journal: Frontiers in immunology

Published: November 02, 2023

Carbenoxolone disodium suppresses the migration of gastric cancer by targeting HDAC6.

Carbenoxolone disodium suppresses the migration of gastric cancer by targeting HDAC6.

Journal: Future medicinal chemistry

Published: March 22, 2023

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?

Journal: Current oncology (Toronto, Ont.)

Published: May 27, 2022

Monobenzone, a Novel and Potent KDM1A Inhibitor, Suppresses Migration of Gastric Cancer Cells.

Monobenzone, a Novel and Potent KDM1A Inhibitor, Suppresses Migration of Gastric Cancer Cells.

Journal: Frontiers in pharmacology

Published: December 12, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026